A detailed history of Diametric Capital, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Diametric Capital, LP holds 1,013 shares of LLY stock, worth $777,740. This represents 0.52% of its overall portfolio holdings.

Number of Shares
1,013
Previous 1,665 39.16%
Holding current value
$777,740
Previous $1.51 Million 40.48%
% of portfolio
0.52%
Previous 0.93%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $503,435 - $625,933
-652 Reduced 39.16%
1,013 $897,000
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $340,688 - $427,248
470 Added 39.33%
1,665 $1.51 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $214,376 - $286,805
362 Added 43.46%
1,195 $929,000
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $259,443 - $305,850
-494 Reduced 37.23%
833 $485,000
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $60,423 - $83,302
139 Added 11.7%
1,327 $712,000
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $416,679 - $557,148
1,188 New
1,188 $557,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $952,590 - $1.09 Million
3,213 New
3,213 $1.04 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $2.24 Million - $2.77 Million
-18,813 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $2.01 Million - $2.49 Million
18,813 New
18,813 $2.47 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $696,757 - $822,476
-9,389 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $769,334 - $825,199
9,389
9,389 $793,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.